An experimental targeted drug could treat a rare type of cancer usually affecting the limbs, a clinical trial led by The Institute of Cancer Research has shown.

The parents of Kelly Turner, Linda and Martin, recently visited The Institute of Cancer Research, London, to see the labs doing research into the cancer that took Kelly’s life.

Combining a cancer-killing virus with immunotherapy could effectively treat advanced cancers that affect the limbs, a new study reveals.